Cartalax is a short peptide compound, commonly identified as Ala-Glu-Asp (AED), studied in preclinical research involving cellular regulation and connective tissue biology. Current evidence is mainly laboratory and animal-based, with limited human research available.
Cartalax 20 mg
Probado por tercerosGarantía de 30 díasPureza 99%+





Reviews
There are no reviews yet.